Anurag K Singh
Roswell Park Cancer Institute · Roswell Park
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
12
all conditions, ClinicalTrials.gov
NIH grants tied to them
3
2 more share only the name and are not shown
Trial papers
150
PubMed author-name match
Trials
Studies that name Anurag K Singh as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:55 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06995508 · Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO TrialRoswell Park Cancer Institute · recruiting · Cancer-Associated Anorexia, Head and Neck Squamous Cell Carcinoma, Neck Squamous Cell Carcinoma of Unknown Primary · principal investigator
- Ph1NCT06670976 · Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue SarcomaRoswell Park Cancer Institute · withdrawn · Soft Tissue Sarcoma · principal investigator
- N/ANCT05338905 · Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT TrialRoswell Park Cancer Institute · active not recruiting · Head and Neck Squamous Cell Carcinoma · principal investigator
- N/ANCT05292521 · Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung CancerRoswell Park Cancer Institute · recruiting · Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 · principal investigator
- Early Ph1NCT04803630 · Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM StudyRoswell Park Cancer Institute · withdrawn · Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm · principal investigator
- N/ANCT04110249 · Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck CancerRoswell Park Cancer Institute · terminated · Head and Neck Carcinoma, Head and Neck Lymph Node, Head and Neck Squamous Cell Carcinoma · principal investigator
- Ph1NCT04073745 · Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung CancerRoswell Park Cancer Institute · active not recruiting · Lung Non-Small Cell Carcinoma, Positive Surgical Margin, Resected Mass · principal investigator
- Ph2NCT04068649 · Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic CancerRoswell Park Cancer Institute · recruiting · Metastatic Malignant Neoplasm · principal investigator
- N/ANCT01007214 · Guided Biopsy for Mapping Prostate CancerRoswell Park Cancer Institute · terminated · Prostate Cancer · principal investigator
- N/ANCT00891904 · Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck CancerRoswell Park Cancer Institute · terminated · Head and Neck Cancer · principal investigator
- Ph2NCT00843726 · Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerRoswell Park Cancer Institute · completed · Lung Cancer · principal investigator
- N/ANCT00796874 · Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active SurveillanceRoswell Park Cancer Institute · withdrawn · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Cancer Stress BiologyP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2026 · $67,181 awarded in 2026Grant number is on one of their registry trials
- Network Lead Academic Participating Site Grant from the Roswell Park Cancer InstituteUG1CA233191 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2019 to 2025 · $305,626 awarded in 2025Same name and institution; not confirmed by an ID
- Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.U10CA180866 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2014 to 2018 · $585,200 awarded in 2018Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Non-invasive assessment of salivary gland function: Translational StudiesR01CA204636 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Mukund Seshadri · fiscal years 2016 to 2019Named on NCT04110249
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:55 UTC. The ranking covers the 200 most relevant of 150 PubMed records, and a shared surname and initials can bring in a namesake. All 150 on PubMed
- Correction of anemia with epoetin alfa in chronic kidney disease.N Engl J Med · 20062,126 citationsRCR 57.7
- A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.N Engl J Med · 20091,655 citationsRCR 46.8
- Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.N Engl J Med · 2019645 citationsRCR 24.0
- Spatial registration of multichannel multi-subject fNIRS data to MNI space without MRI.Neuroimage · 2005561 citationsRCR 16.5
- Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.J Clin Oncol · 2019477 citationsRCR 22.5
- Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.Kidney Int · 2008448 citationsRCR 12.9
- Erythropoietic response and outcomes in kidney disease and type 2 diabetes.N Engl J Med · 2010381 citationsRCR 11.2
- Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials.Nat Med · 2023357 citationsRCR 30.6
- A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927).Int J Radiat Oncol Biol Phys · 2015342 citationsRCR 14.1
- A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease.J Am Soc Nephrol · 2003327 citationsRCR 10.1